Brendan McGovern
Analyst · a number of factors including those described from time to time in the Company's SEC filings. Yesterday after the market closed the Company issued an earnings press release and posted a supplemental earnings presentation, both of which can be found on the home page of our website at www.GoldmanSachsBDC.com under the investor resources section. These documents should be reviewed in conjunction with the Company's Form 10-Q filed yesterday with the SEC. This conference call is being recorded today, May 10, 2016, for replay purposes. I will now turn the call over to Brendan McGovern, the Chief Executive Officer of Goldman Sachs BDC, Inc
Thank you, Dennis. Good morning, everyone and thank you for joining us for our Q1 earnings conference call. I will start by providing an overview of the first quarter. Then I will turn the call over to Jon Yoder to discuss our investment activities. Jonathan Lamm, our CFO, will take you through a detailed discussion of our financial results and finally, I will conclude with some closing remarks before we take questions. So with that, Q1 net investment income was $0.58 per share as compared to $0.52 per share for Q1 of 2015 and $0.62 per share for Q4 of 2015. The year-over-year improvement in NII per share reflected higher earning assets, coupled with a reduction of incentive fees owing to unrealized portfolio markdowns. As compared to Q4 of 2015, NII per share was modestly lower due to higher incentive fee and lower other income. As we announced after close yesterday, our Board declared a $0.45 per share dividend payable to shareholders of record as of June 30. This quarter net investment income exceeded the dividend by almost 30%, continuing the trend of extremely strong dividend coverage that our business model and expense structure is designed to produce. In fact, since our IPO more than a year ago, net investment income has exceeded dividends by a total of 18%. Moving on to investment activity, thematically the first quarter was notable for its relatively muted transaction volumes. However, we continue to benefit from a stable balance sheet and we produced modest net portfolio growth while remaining well within our target leverage ratio. Moreover, we do not recognize all origination fee revenue up front, but rather be amortize this fee income over the life of the loan. As a result, we're not dependent on new originations each quarter to produce one-time fee income to cover our dividend. In a quarter like this, when some competitors struggle to repeat higher NII levels given lower industry-wide transaction volumes, the quality of our income becomes apparent. Also, as a reminder, during Q1 our Board of Directors approved a 10b5-1 plan for GS BDC to purchase up to $25 million of its common stock if the stock price is below our most recently announced NAV, subject to limitations. This plan commenced in March and we believe the new plan provides shareholders with the benefit of NAV accretion in the event the Company is able to buy back shares below NAV. Since the plan took effect March, the Company did not purchase any shares under the plan as our stock traded above NAV. Finally, moving on to credit quality. First, we're pleased to report that two investments we discussed last quarter, GTL and Securus, showed positive trends and a reversal of a portion of the unrealized mark-to-market declines in prior quarters. These investments benefited from a favorable court ruling that stayed a new regulation which had the potential to put downward pressure on both companies' revenue. As a result of the court ruling, both companies have continued produce strong financial results and cash flow and deleveraging trends. Thus far in Q2 we have continued to see positive mark-to-market gains and trading levels for these two investments. Offsetting this positive event, however, was the markdown of our investment in Hunter Defense which was placed on nonaccrual status during the quarter. I would like to pause here for a moment, so we can give you as much transparency on this investment as possible. Hunter makes shelters and other ancillary products that are used by the U.S. military in mobile troop deployments. We owned $20 million in face amount of a second-lien loan which were marked at 45% of par at quarter end. Our initial investment thesis centered on a few key themes. First, Hunter is far and away the market share leader for its products and for a large portion of its revenue, it is the only provider of products to its customers. Its business has very high barriers to entry which is a function of demanding regulatory and customer requirements. Demand for its products has historically been correlated with troop deployment which has been stable at what we believe have been trough levels for the last two years. And, finally, the company had a sensible capitalization with approximately 40% sponsor equity cushion beneath our loan and overall debt levels that were a relatively low multiple of cash flow in comparison with industry averages. As we fast-forward to our initial investment, the core attributes of our underwriting thesis remain intact. Hunter has maintained its strong market share position and key demand drivers of its business remain stable. Clearly, however, a nonaccrual is not the outcome we anticipated when we underwrote this investment. Looking back, we underestimated the degree and speed with which the Company's revenue could decline, even in the absence of -- changes to what we believe to be some of the key demand drivers of the business. While we don't believe the company's long term prospects have been permanently impaired, short term uncertainty persists. Over the course of the first quarter, the company experienced a disruption in revenue which we believe developed due to new military procurement systems order processing issues, as well as from changes in military spending prioritization. This abrupt change in the company's financial condition caused liquidity to tighten, resulting in the nonpayment of our interest at quarter end. Looking forward, we're hopeful that we can reach a consensual resolution among all the company's stakeholders, including the financial sponsor, who has capital beneath our second-lien loan. While the situation is fluid, at present we anticipate a consensual recapitalization and we're considering an incremental investment into the company. If successful, we believe this recapitalization may provide a pathway to recouping our investment as Hunter's business normalizes. Importantly, I want to note that Hunter is the only investment in the portfolio on nonaccrual status and represents just 1.2% of the portfolio at fair value and 2.3% at amortized cost. With that, let me turn it over to Jon Yoder.